Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cellsAstrid Bernhaus, Thomas Szekeres, Andreas Lackner et al.|Investigational New Drugs|2008Cited by 28
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosineThomas Szekeres, Philipp Saiko, Monika Fritzer‐Szekeres et al.|International Journal of Oncology|2007Cited by 23